| Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis? D Bozkurt, S Sipahi, P Cetin, E Hur, Ö Özdemir, M Ertilav, S Sen, ... Peritoneal dialysis international 29 (2_suppl), 206-210, 2009 | 43 | 2009 |
| The role of therapeutic plasmapheresis in patients with hyperthyroidism OO Baser, Z Cetin, M Catak, D Koseoglu, D Berker Transfusion and Apheresis Science 59 (4), 102744, 2020 | 20 | 2020 |
| Clinical and hormonal characteristics of patients with different types of hypophysitis: a single-center experience NN Imga, AE Yildirim, OO Baser, D Berker Archives of Endocrinology and Metabolism 63, 47-52, 2019 | 20 | 2019 |
| Serum zonulin level is not elevated in patients with polycystic ovary syndrome without metabolic syndrome Z Cetin, A Kosem, B Can, O Baser, M Catak, T Turhan, D Berker Archives of Gynecology and Obstetrics 300, 1785-1790, 2019 | 9 | 2019 |
| Malignancy outcomes and the impact of repeat fine needle aspiration of thyroid nodules with Bethesda category III cytology: A multicenter experience D Köseoğlu, Ö Özdemir Başer, Z Çetin Diagnostic Cytopathology 49 (10), 1110-1115, 2021 | 6 | 2021 |
| The role of inflammation, oxidation and Cystatin-C in the pathophysiology of polycystic ovary syndrome ÖÖ Başer, AY Göçmen, DA Kırmızı Turkish Journal of Obstetrics and Gynecology 19 (3), 229, 2022 | 4 | 2022 |
| The Detection of Preoperative Parathyroid Lesions: The Success of Ultrasonography, Technetium-99m Methoxyisobutylisonitrile Parathyroid Scintigraphy, and Single-Photon Emission … OO Baser, D Koseoglu, Z Cetin, M Catak, D Berker Endocrine Practice 27 (12), 1193-1198, 2021 | 4 | 2021 |
| The effects of salt consumption habits on iodine status and thyroid functions duringpregnancy M Apaydin, T Demirci, ÖÖ Başer, B Uçan, M Özbek, E Çakal Turkish Journal of Medical Sciences 51 (2), 766-771, 2021 | 4 | 2021 |
| Exenatide treatment reduces thyroid gland volume, but has no effect on the size of thyroid nodules D Köseoğlu, ÖÖ Başer, D Berker, S Güler Acta Endocrinologica (Bucharest) 16 (3), 275, 2020 | 4 | 2020 |
| Benign cytology does not rule out malignancy in thyroid nodules larger than 4 cm OO Baser, D Koseoglu, Z Cetin, M Catak, H Kizilkaya Diagnostic Cytopathology 50 (11), 508-512, 2022 | 2 | 2022 |
| The relationship of thyroid functions with ADMA, IMA, and metabolic laboratory parameters in Euthyroid adults with and without autoimmune thyroiditis Z Cetin, A Kosem, M Catak, B Can, O Baser, S Guler Laboratory Medicine 53 (3), 290-295, 2022 | 2 | 2022 |
| Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetesmellitus: a prospective study D Köseoğlu, SS Koparal, ÖÖ Başer, D Berker Turkish Journal of Medical Sciences 51 (1), 167-174, 2021 | 2 | 2021 |
| Hashimoto’s thyroiditis is not a negative contributor to papillary thyroid cancer Z Çetin, Ö Başer, S Güler | 1 | 2022 |
| Clinical, sonographical and cytological comparison of toxic and non-toxic thyroid nodules Z Çetin, D Köseoğlu, ÖÖ BAŞER Journal of Health Sciences and Medicine 5 (3), 922-925, 2022 | | 2022 |
| Can eosinophil to monocyte ratio be a new marker for recurrence in graves' disease? OO Baser, D Koseoglu, M Catak Medicine 11 (4), 1436-40, 2022 | | 2022 |
| Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study Ö Baser, D Koseoglu, Z Cetin, M Catak HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI 60 (2), 2022 | | 2022 |
| Monocyte and neutrophil to high density lipoprotein cholesterol ratios are elevated in patients with vitamin D deficiency D Köseoğlu, ÖÖ Başer, Z Çetin, M Çatak Journal of Health Sciences and Medicine 5 (1), 119-123, 2022 | | 2022 |
| Does sufficient 25-hydroxyvitamin D mean lower metabolic risk for women? Z Cetin, O Baser, D Koseoglu, M Catak Mediterranean Journal of Nutrition and Metabolism 13 (4), 311-318, 2020 | | 2020 |
| Kan Grupları, Gestasyonel Diyabet için Bir Risk Faktörü Müdür? M Apaydın, Ö Özdemir, T Demirci, C Varım Sakarya Tıp Dergisi 10 (2), 205-209, 2020 | | 2020 |
| Should narrower TSH and free thyroid hormone levels be targeted to reduce the cardiovascular risk of euthyroid subjects? Z Cetin, A Kosem, M Catak, B Can, O Baser, T Turhan, D Berker, S Guler Endocrine Abstracts 63, 2019 | | 2019 |
